An Economic Evaluation of rt-PA Locking Solution in Dialysis Catheters

In a recent randomized trial, weekly recombinant tissue plasminogen activator (rt-PA), 1 mg per lumen, once per week, and twice-weekly heparin as a locking solution (rt-PA/heparin) resulted in lower risks of hemodialysis catheter malfunction and catheter-related bacteremia compared with thrice-weekl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Am Soc Nephrol
Autori principali: Manns, Braden J., Scott-Douglas, Nairne, Tonelli, Marcello, Ravani, Pietro, LeBlanc, Martine, Dorval, Marc, Holden, Rachel, Moist, Louise, Lok, Charmaine, Zimmerman, Deborah, Au, Flora, Hemmelgarn, Brenda R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Nephrology 2014
Soggetti:
Clinical Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4243340/
https://ncbi.nlm.nih.gov/pubmed/25012176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013050463
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi